MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-TS-09-0052302
Laxai Life Sciences Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹178 Cr
▲ 37% YoY
Net profit · FY 2024
₹6.75 Cr
Net margin 3.8%
EBITDA · FY 2024
₹20.02 Cr
EBITDA margin 11.2%
Authorised capital
₹32 Cr
Registered with MCA
Paid-up capital
₹27.79 Cr
Issued & subscribed
Open charges
₹26.56 Cr
Satisfied ₹164.63 Cr
Company age
20 yrs
Est. 2006
Employees · EPFO
345
Provident fund records
About Laxai Life Sciences Private Limited
Data last updated:
Laxai Life Sciences Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 10 July 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24119TG2006PTC050583. Its GSTIN is 36AABCL2022R1ZE (Telangana). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹32 Cr and a paid-up capital of ₹27.79 Cr. It was formerly known as Laxai - Avanti Life - Sciences Private Limited. It is led by directors including Lavanya Gali and Nikhil Puri.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2024, the company reported a revenue of ₹178 Cr, a growth of 37% compared to the previous year. For the same year it recorded a net profit of ₹6.75 Cr (net margin 3.8%) and EBITDA of ₹20.02 Cr (EBITDA margin 11.2%). Revenue has grown at a compounded annual rate (CAGR) of 57% over three years and 49% over five years.
The company has about 345 employees on its provident fund (EPFO) records.
The company is associated with 2 brands: Epione Labs and LAXAI. As per MCA filings, the company has open charges of ₹26.56 Cr and satisfied charges of ₹164.63 Cr on record. Court records list 10 cases involving the company, including 6 filed by the company and 4 filed against it; 6 cases are pending. The company has 31 deals on record (20 secondary share transfers, 7 funding rounds, 4 convertible or debt financings), with disclosed funding of ₹228.92 Cr; the latest was in March 2023. Its 3 peer companies in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development) are compared by revenue, 1 larger and 2 smaller; the largest is Pioneer Hi-Bred Private Limited with revenue of ₹207.84 Cr. The company has 19 MSME Form 1 returns on record between 2016 and 2021, listing 1,471 overdue payments to 37 micro and small suppliers.
Laxai Life Sciences Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-TS-09-0052302). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website laxai.com.
Company details
CIN U24119TG2006PTC050583
Registration Number 050583
Incorporation Date 10 July 2006
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-TS-09-0052302
CIN history
Laxai Life Sciences has one previous CIN (Corporate Identification Number): U24119AP2006PTC050583. The current CIN is U24119TG2006PTC050583, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24119TG2006PTC050583 | Current |
| U24119AP2006PTC050583 | Previous |
Recognitions & Rankings of Laxai Life Sciences
Contact details
Laxai Life Sciences Private Limited's registered office is in Hyderabad, Telangana. Its website is laxai.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressPlot No. 40 & 41 Third Floor Ventureast Plaza Road No. 2 Financial District Nanakram, Guda, Hyderabad, Telangana, India – 500032
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Laxai Life Sciences Private Limited, buy the company report.
Comprehensive company report
Laxai Life Sciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Laxai Life Sciences operates two associated brands: Epione Labs and LAXAI. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| A CDMO specializing in the manufacturing of active pharmaceutical ingredients. | epionelabs.com | |
| Drug discovery and development services are provided by LAXAI. | laxai.com |
Business activity
The main business activity of Laxai Life Sciences is professional, scientific and technical. In detail, this covers scientific research and development.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Laxai Life Sciences Private Limited, buy the company report.
Financials of Laxai Life Sciences Private Limited
FY 2024 filings availableLaxai Life Sciences Private Limited reported revenue of ₹178 Cr (up 37% YoY) for FY 2024.
Revenue · FY 2024
₹178 Cr ▲ 37%
Net profit · FY 2024
₹6.75 Cr margin 3.8%
EBITDA · FY 2024
₹20.02 Cr margin 11.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 37%
3 years · compounded
▲ 57%
5 years · compounded
▲ 49%
EBITDA CAGR growth
1 year
▲ 165%
3 years · compounded
▲ 82%
5 years · compounded
▲ 22%
Revenue has grown at a compounded annual rate (CAGR) of 49% over five years, including 37% growth in the latest year. EBITDA rose 165% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹20.02 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹6.75 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.2% | ||||
| Net Profit Margin | 3.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Laxai Life Sciences Private Limited, buy the company report.
Board of directors of Laxai Life Sciences Private Limited
Laxai Life Sciences has 3 current directors and 18 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Lavanya Gali Also directs: Global Freight Terminal Private Limited, Emev Private Limited, Laxai Biopharma Private Limited and 1 more | Director | 28 Mar 2023 | 3 Years 7 Months | Current |
| Nikhil Puri | Director | 23 Mar 2023 | 3 Years 7 Months | Current |
| Venkatraman Ganesh Also directs: Laxai Biopharma Private Limited, Vasant Chemicals Private Ltd. | Director | 21 Mar 2025 | 1 Years 7 Months | Current |
Peer comparison
Laxai Life Sciences Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Pioneer Hi-Bred Private Limited | ₹207.84 Cr (FY 2025) | 16.0% | Hyderabad, Telangana, India | |||
| Laxai Life Sciences Private Limitedthis company | ₹178 Cr (FY 2024) | ₹6.75 Cr | 3.8% | 37.0% | 345 | Hyderabad, Telangana, India |
| Aurigene Oncology Limited | ₹171.93 Cr (FY 2025) | -57.0% | Bangalore, Karnataka, India | |||
| Amgen Technology Private Limited | ₹166.38 Cr (FY 2025) | 601.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Laxai Life Sciences Private Limited, buy the company report.
Auditor
Laxai Life Sciences Private Limited is audited by KVSRY & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KVSRY & Associates | FY 2023 | 008169S |
Shareholding
The shareholding of Laxai Life Sciences Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Laxai Life Sciences Private Limited, buy the company report.
Charges & borrowings
Open charges
₹26.56 Cr
Satisfied charges
₹164.63 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 11 Oct 2024 | 101002940 | Hdfc Bank Limited | ₹21.12 Lakh | Open | |
| 06 Sep 2024 | 100986845 | Hdfc Bank Limited | ₹1.35 Cr | Open | |
| 07 Mar 2024 | 100885202 | Others | ₹25 Cr | Open | |
| 11 Dec 2023 | 100863094 | Hdfc Bank Limited | ₹40 Lakh | Satisfied | |
| 29 Apr 2020 | 100429697 | Others | ₹30 Lakh | Satisfied |
To see the full charge records of Laxai Life Sciences Private Limited, buy the company report.
Total charge records: 11 View all charges
Deals & funding
Laxai Life Sciences Private Limited has 31 deals on record (20 secondary share transfers, 7 funding rounds, 4 convertible or debt financings), with disclosed funding of ₹228.92 Cr; the latest was in March 2023.
Total deals
31
Secondary share transfers
20
Funding rounds
7
Convertible or debt financings
4
Disclosed funding
₹228.92 Cr
Deals on record (5 of 31)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2023 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Foray Universal Consultancy Services Private Limited |
| Oct 2022 | Secondary share transfer | Undisclosed | Buyer: Laxai Inc Seller: Niveza Wealth Management Private Limited |
| Sep 2022 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Niveza Wealth Management Private Limited |
| Jul 2021 | Secondary share transfer | Undisclosed | Buyer: P.C.S.Securities Limited Seller: an individual |
| Dec 2019 | Secondary share transfer | Undisclosed | Buyer: Niveza Wealth Management Private Limited Seller: Sharp Ventures |
To see the full deal history of Laxai Life Sciences Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Laxai Life Sciences Private Limited has 10 court cases on record: 6 filed by Laxai Life Sciences, 4 filed against it. 6 cases are pending and 4 are disposed.
Total cases
10
Filed by the company
6
Filed against the company
4
Pending
6
Disposed
4
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 5 | 1 | 5 |
| High courts | 4 | 2 | 1 |
| NCLT | 1 | 1 | 0 |
Cases on record (5 of 10)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, TELANGANA | Arbitration matter | Filed against the company by M/S. Uniworks Designs Pvt. Ltd. | Disposed |
| NCLT, Hyderabad | Court case (COMP.APPL) | Filed against the company by Omnicare Drugs India Private Limited | Disposed |
| High Court, TELANGANA | Arbitration matter | Filed by the company against M/S. Therapiva Private Limited. and 1 other | Disposed |
| District court, Rangareddy, Telangana | Civil suit | Filed by the company against M/S. Krouzon Pharmaceuticals Inc. | Pending |
| District court, Rangareddy, Telangana | Civil suit | Filed by the company against an individual | Pending |
To see the full case history of Laxai Life Sciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Laxai Life Sciences Private Limited was last rated by Indiarating on 12 Aug 2021.
| Rating agency | Rated on | Rating |
|---|---|---|
| Indiarating | 12 Aug 2021 |
To see the full credit ratings and regulatory alerts of Laxai Life Sciences Private Limited, buy the company report.
MSME payment delays
Laxai Life Sciences Private Limited has 19 MSME Form 1 returns on record between 2016 and 2021, listing 1,471 overdue payments to 37 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 37)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Hyma Synthesis Private Limited | |||
| an individual supplier | |||
| Lab Needs | |||
| Alr Labs Private Limited | |||
| Sethiya Chemicals Private Limited |
To see the full MSME payment records of Laxai Life Sciences Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Laxai Life Sciences has 1 associated company. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.
1
Associated companies
Employees & EPFO
Laxai Life Sciences Private Limited has a workforce of 345 employees on its EPFO records as of Mar 28, 2024, across 1 active EPFO establishment.
Employee count
345
Active EPFO establishments
1
Employee growth
44.96%
GST
Laxai Life Sciences has 3 GST registrations: 1 active and 2 cancelled or inactive.
Total GSTINs
3
Active
1
Cancelled / inactive
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AABCL2022R1ZE | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Laxai Life Sciences Private Limited, buy the company report.
Recent activity
Laxai Life Sciences Private Limited has 18 board changes on record since 2009: 3 appointments and 15 cessations. The latest: Venkatraman Ganesh ceased to be Additional Director on 29 Sep 2025.
Ceased
Venkatraman Ganesh ceased to be Additional Director.
Appointed
Venkatraman Ganesh was appointed as Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.21 Cr with Charge ID 101002940 was registered on 11 Oct 2024.
AGM
Laxai Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
A charge registered on 11 Dec 2023 via Charge ID 100863094 with Hdfc Bank Limited was fully satisfied on 21 Sep 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 1.35 Cr with Charge ID 100986845 was registered on 06 Sep 2024.
Filing
Laxai Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Charges
A charge registered on 06 Jul 2017 via Charge ID 100122991 with Others was fully satisfied on 18 Mar 2024.
Charges
A charge with Others amounted to Rs. 25.00 Cr with Charge ID 100885202 was registered on 07 Mar 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.40 Cr with Charge ID 100863094 was registered on 11 Dec 2023.
Charges
A charge registered on 29 Apr 2020 via Charge ID 100429697 with Others was fully satisfied on 05 Oct 2023.
Charges
A charge registered on 31 Oct 2015 via Charge ID 10605859 with Reliance Capital Ltd was fully satisfied on 03 Oct 2023.
30 earlier events are in the company report.
News
Frequently asked questions
Laxai Life Sciences is an active private limited company based in Hyderabad, Telangana, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 10 July 2006 (20+ years old) and is registered under CIN U24119TG2006PTC050583.
Laxai Life Sciences has 3 current directors:
- Lavanya Gali - Director
- Nikhil Puri - Director
- Venkatraman Ganesh - Director
The latest financial statements of Laxai Life Sciences on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Laxai Life Sciences is 36AABCL2022R1ZE, registered in Telangana. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Laxai Life Sciences is U24119TG2006PTC050583. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Laxai Life Sciences has 10 court cases on record: 6 filed by the company and 4 filed against it. 6 are pending. Most are in the district courts.
Laxai Life Sciences was incorporated on 10 July 2006, making it 20+ years old. It is registered with the Registrar of Companies, Hyderabad.
Laxai Life Sciences has 31 deals on record (20 secondary share transfers, 7 funding rounds, 4 convertible or debt financings), with disclosed funding of ₹228.92 Cr; the latest was in March 2023.
The peers of Laxai Life Sciences by revenue are Pioneer Hi-Bred Private Limited, Aurigene Oncology Limited, Amgen Technology Private Limited, all in the Pharma industry (Contract Research), with the same principal business activity (scientific research and development).
Venkatraman Ganesh ceased to be Additional Director on 29 Sep 2025. Venkatraman Ganesh was appointed as Director on 21 Mar 2025. Nagajayanthi Ragavendra Das Juttur ceased to be Additional Director on 19 Sep 2023. Laxai Life Sciences has 18 board changes on record in total.
Yes, Laxai Life Sciences is registered as an MSME under Udyam registration (number: UDYAM-TS-09-0052302).
Laxai Life Sciences has 19 MSME Form 1 returns on record between 2016 and 2021, listing 1,471 overdue payments to 37 micro and small suppliers. The latest return was filed on 28 Oct 2021.